FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890920903> ?p ?o ?g. }

• W2890920903 endingPage "232" @default.
• W2890920903 startingPage "222" @default.
• W2890920903 abstract "Anoikis-resistance is a critical step in cancer progression, especially during the process of metastasis. During this phase, the cancer phenotype that causes cell survival in detachment conditions, drug resistance, and epithelial-to-mesenchymal transition (EMT) is altered. Inhibition of anoikis-resistance can potentially be the molecular target in cancer therapy. Alpha-mangostin, an active compound in Garcinia mangostana, has been reported for its cell-death induction and its chemosensitizing and anti-metastatic properties in many cancer cell types, such as ovarian cancer, lung cancer, and hepatocellular carcinoma. We, therefore, have investigated whether alpha-mangostin could sensitize anoikis in human hepatocellular carcinoma (HepG2). The established anoikis-resistant HepG2 displayed more aggressive malignant behaviors, including rapid proliferation, doxorubicin resistance, up-regulated anti-apoptotic protein levels, and EMT phenotype. Alpha-mangostin significantly sensitized anoikis in HepG2 through the inhibition of cell survival by induced caspase-9, caspase-8 and caspase-3 activities, increased pro-apoptotic protein (Bax, Bim, t-Bid) levels, and decreased anti-apoptotic protein (c-FLIP, Mcl-1) levels. Besides, alpha-mangostin significantly reduced cell re-adhesion and migration, matrix metalloproteinases-2 (MMP-2) and MMP-9 secretions, and EMT-involved protein (N-cadherin, αV, β1 integrin, and vimentin) expressions. AKT and ERK signaling pathways were dramatically suppressed, which indicated that alpha-mangostin inhibited anoikis-resistance via the inhibition of these pathways in HepG2. These findings support the development of alpha-mangostin to be used in the treatment of anoikis-resistant liver cancer." @default.
• W2890920903 created "2018-09-27" @default.
• W2890920903 creator A5016695745 @default.
• W2890920903 creator A5050914555 @default.
• W2890920903 creator A5055281353 @default.
• W2890920903 date "2018-12-01" @default.
• W2890920903 modified "2023-10-16" @default.
• W2890920903 title "Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells" @default.
• W2890920903 cites W1497663772 @default.
• W2890920903 cites W1649474707 @default.
• W2890920903 cites W1794035567 @default.
• W2890920903 cites W1967294574 @default.
• W2890920903 cites W1973890143 @default.
• W2890920903 cites W1981432984 @default.
• W2890920903 cites W1987807963 @default.
• W2890920903 cites W1989242694 @default.
• W2890920903 cites W1995614441 @default.
• W2890920903 cites W2000718490 @default.
• W2890920903 cites W2000913350 @default.
• W2890920903 cites W2003500892 @default.
• W2890920903 cites W2003673642 @default.
• W2890920903 cites W2005839814 @default.
• W2890920903 cites W2006350927 @default.
• W2890920903 cites W2010929360 @default.
• W2890920903 cites W2016808773 @default.
• W2890920903 cites W2025647419 @default.
• W2890920903 cites W2030694827 @default.
• W2890920903 cites W2034937845 @default.
• W2890920903 cites W2056717107 @default.
• W2890920903 cites W2058634928 @default.
• W2890920903 cites W2059373592 @default.
• W2890920903 cites W2059530905 @default.
• W2890920903 cites W2075371963 @default.
• W2890920903 cites W2076583198 @default.
• W2890920903 cites W2080064317 @default.
• W2890920903 cites W2081810700 @default.
• W2890920903 cites W2089693511 @default.
• W2890920903 cites W2091823826 @default.
• W2890920903 cites W2097761831 @default.
• W2890920903 cites W2106787323 @default.
• W2890920903 cites W2110187114 @default.
• W2890920903 cites W2111865362 @default.
• W2890920903 cites W2133817220 @default.
• W2890920903 cites W2137022580 @default.
• W2890920903 cites W2138362890 @default.
• W2890920903 cites W2138552942 @default.
• W2890920903 cites W2142977207 @default.
• W2890920903 cites W2145139438 @default.
• W2890920903 cites W2151960655 @default.
• W2890920903 cites W2163134976 @default.
• W2890920903 cites W2165200432 @default.
• W2890920903 cites W2165674962 @default.
• W2890920903 cites W2166807378 @default.
• W2890920903 cites W2172589846 @default.
• W2890920903 cites W2186340798 @default.
• W2890920903 cites W2260600960 @default.
• W2890920903 cites W2287862469 @default.
• W2890920903 cites W2291055813 @default.
• W2890920903 cites W2430181225 @default.
• W2890920903 cites W2500752633 @default.
• W2890920903 cites W2509675510 @default.
• W2890920903 cites W2579691966 @default.
• W2890920903 cites W2612677677 @default.
• W2890920903 cites W2613011186 @default.
• W2890920903 cites W2748218427 @default.
• W2890920903 cites W2774169295 @default.
• W2890920903 cites W2801537574 @default.
• W2890920903 cites W2809375742 @default.
• W2890920903 cites W4211224216 @default.
• W2890920903 doi "https://doi.org/10.1016/j.tiv.2018.09.003" @default.
• W2890920903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30195041" @default.
• W2890920903 hasPublicationYear "2018" @default.
• W2890920903 type Work @default.
• W2890920903 sameAs 2890920903 @default.
• W2890920903 citedByCount "18" @default.
• W2890920903 countsByYear W28909209032019 @default.
• W2890920903 countsByYear W28909209032020 @default.
• W2890920903 countsByYear W28909209032021 @default.
• W2890920903 countsByYear W28909209032022 @default.
• W2890920903 countsByYear W28909209032023 @default.
• W2890920903 crossrefType "journal-article" @default.
• W2890920903 hasAuthorship W2890920903A5016695745 @default.
• W2890920903 hasAuthorship W2890920903A5050914555 @default.
• W2890920903 hasAuthorship W2890920903A5055281353 @default.
• W2890920903 hasConcept C121608353 @default.
• W2890920903 hasConcept C126322002 @default.
• W2890920903 hasConcept C147447768 @default.
• W2890920903 hasConcept C152000582 @default.
• W2890920903 hasConcept C185592680 @default.
• W2890920903 hasConcept C190283241 @default.
• W2890920903 hasConcept C203014093 @default.
• W2890920903 hasConcept C204232928 @default.
• W2890920903 hasConcept C2779013556 @default.
• W2890920903 hasConcept C2909826119 @default.
• W2890920903 hasConcept C502942594 @default.
• W2890920903 hasConcept C55493867 @default.
• W2890920903 hasConcept C556039675 @default.
• W2890920903 hasConcept C71924100 @default.

• next